Risk of cardiovascular events with cyclin-dependent kinases 4 and 6 (CDK 4/6) inhibitors among patients with metastatic breast cancer: A systematic review and network meta-analysis

被引：0
|
作者：
Liu, Yi-Shao [1 ]
Dong, Kevin [1 ]
Park, Chanhyun [2 ]
机构：
[1] Univ Texas Austin, Austin, TX USA
[2] Univ Texas Austin, Coll Pharm, Hlth Outcomes Div, Austin, TX USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1218
引用
收藏
页码：575 / 576
页数：2
相关论文
共 50 条
  • [31] Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis
    Bolzacchini, Elena
    Pomero, Fulvio
    Fazio, Martina
    Civitelli, Chiara
    Fabro, Giulia
    Pellegrino, Domenico
    Giordano, Monica
    Squizzato, Alessandro
    THROMBOSIS RESEARCH, 2021, 208 : 190 - 197
  • [32] Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors
    Kapagan, Tanju
    Bulut, Nilufer
    Erdem, Gokmen Umut
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (08) : 1403 - 1410
  • [33] The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
    Petrelli, Fausto
    Dottorini, Lorenzo
    Di Menna, Giandomenico
    Borgonovo, Karen
    Parati, Maria Chiara
    Rea, Carmen Giusy
    Ghilardi, Mara
    Ghidini, Antonio
    Luciani, Andrea
    BREAST, 2023, 71 : 138 - 142
  • [34] Concurrent Use of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors with Palliative Radiotherapy for Metastatic Breast Cancer Patients: A Review of Toxicity
    Sonmez, Ozlem
    Tezcanli, Evrim
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2021, 36 (04): : 538 - 542
  • [35] Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer
    Hassan, Mohammed Al-Kassim
    Ates-Alagoz, Zeynep
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (04) : 412 - 428
  • [36] Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy
    Migliaccio, Ilenia
    Di Leo, Angelo
    Malorni, Luca
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 568 - 575
  • [37] Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
    Graf, F.
    Mosch, B.
    Koehler, L.
    Bergmann, R.
    Wuest, F.
    Pietzsch, J.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (06) : 527 - 539
  • [38] Targeting androgen receptors and cyclin-dependent kinases 4 and 6 in breast cancer
    Tien, Amy H.
    Mawji, Nasrin R.
    Wang, Jun
    Sadar, Marianne D.
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women
    Cersosimo, Robert J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (16) : 1183 - 1202
  • [40] Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors
    Pathak, Neha
    Mittal, Abhenil
    Kumar, Sudhir
    Nagpal, Chitrakshi
    Amir, Eitan
    Haldar, Partha
    Gangadharaiah, Bharath B.
    Kumar, Akash
    Mishra, Ashutosh
    Batra, Atul
    CURRENT ONCOLOGY, 2025, 32 (01)
12345